UBS Group AG - AMPLIPHI BIOSCIENCES CORP ownership

AMPLIPHI BIOSCIENCES CORP's ticker is APHB and the CUSIP is 03211P301. A total of 28 filers reported holding AMPLIPHI BIOSCIENCES CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AMPLIPHI BIOSCIENCES CORP
ValueSharesWeighting
Q1 2019$0
-100.0%
11
-100.0%
0.00%
Q4 2018$7,000
+250.0%
35,029
+1964.2%
0.00%
Q3 2018$2,000
-75.0%
1,697
-77.4%
0.00%
Q2 2018$8,0007,495
+187275.0%
0.00%
Q1 2018$0
-100.0%
4
-99.9%
0.00%
Q4 2017$3,000
-82.4%
3,225
-82.4%
0.00%
Q3 2017$17,000
+54.5%
18,355
+35.6%
0.00%
Q2 2017$11,00013,5350.00%
Other shareholders
AMPLIPHI BIOSCIENCES CORP shareholders Q2 2018
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 731,409$570,0000.04%
A.R.T. Advisors, LLC 42,057$32,0000.00%
MSD Partners, L.P. 15,011$12,0000.00%
UBS Group AG 13,535$11,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 37,449$29,0000.00%
DEUTSCHE BANK AG\ 1$00.00%
PANAGORA ASSET MANAGEMENT INC 4,870$4,0000.00%
MORGAN STANLEY 6$00.00%
BlackRock Inc. 77$00.00%
SYNOVUS FINANCIAL CORP 15,000$12,0000.00%
View complete list of AMPLIPHI BIOSCIENCES CORP shareholders